Free CME from PeerView


Endocrinology & Diabetes CME

Credits: 1.0 CME
Joslin Diabetes Center
A Call to Action for Primary Care Professionals: Your Role in Saving the Eyesight of Patients With Diabetes
Mark W. Stolar, MD
September 30, 2022
Credits: 0.5 CME
University of Florida College of Medicine
Envisioning the Future of Hyperlipidemia Management: How Can We Leverage PCSK9-Targeting Therapies to Prevent Primary and Secondary Cardiovascular Events?
Norman E. Lepor, MD, FACC, FAHA, FSCAI
September 29, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Optimizing NTRK Fusion Testing and TRK Inhibition in Thyroid Cancer: Team-Based Approaches for Enhanced Outcomes
Marcia S. Brose, MD, PhD, FASCO
September 26, 2022
Credits: 1.0 CME
PVI, PeerView Institute for Medical Education
Getting Ahead of the Curve: Identifying and Managing Obesity in Primary Care
Domenica M. Rubino, MD
July 28, 2022
Credits: 1.5 CME
Joslin Diabetes Center
A Call to Action for Diabetes Specialists: Your Role in Saving the Eyesight of Patients With Diabetes
Richard Beaser, MD
July 12, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
A Renewed Look at MRA Therapy: Improving Renal Outcomes and Reducing Risks in Patients With Type 2 Diabetes
Rajiv Agarwal, MD, MS
May 13, 2022
Credits: 1.0 CME / NCPD / CE
PVI, PeerView Institute for Medical Education
Building Skills for Clinical Practice: Optimizing Insulin Management and Personalizing Diabetes Care With Faster-Acting Formulations and Newer Options in Delivery Technology
Lucia M. Novak, MSN, ANP-BC, BC-ADM
April 27, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
Is Synergism the Secret to Success? Candid Conversations on Targeting GIP and GLP-1 to Individualize Treatment in Patients With T2DM and Obesity
Javier Morales, MD, FACP, FACE
April 08, 2022
Credits: 0.5 CME
Medical Learning Institute, Inc.
Complementary Actions All Around: Lowering Cardiometabolic Risks While Achieving Glycemic Targets With GLP-1 RAs
John B. Buse, MD, PhD
March 25, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Putting the Pieces Together: Would You Recognize Acute Hepatic Porphyria If You Saw It?
Herbert L. Bonkovsky, MD
February 25, 2022
Rohit Loomba, MD, MHSc
Credits: 0.5 CME
AGA Institute
Test Your Knowledge of What’s Now and What’s Next: Modification of Metabolic Risk Factors to Improve Liver-Related and Cardiovascular‐Related Outcomes in NASH
Rohit Loomba, MD, MHSc
February 10, 2022
Bradley S. Miller, MD, PhD
PVI, PeerView Institute for Medical Education
Advances in Pediatric Growth Hormone Therapy: Visualizing the Impact on Individualized Care
Bradley S. Miller, MD, PhD
December 30, 2021
Penn State College of Medicine
Clinical Colloquia in Retinal Disease: Updating Evidence-Based, Patient-Centered Care for Diabetic Retinopathy
Carl Regillo, MD
November 22, 2021
Domenica M. Rubino, MD/Donna H. Ryan, MD, FTOS
Medical Learning Institute, Inc.
Gut Feeling: The Increasing Importance of GLP-1–Based Therapies for Personalized Obesity Management
Domenica M. Rubino, MD /
November 09, 2021
Medical Learning Institute, Inc.
The Contemporary Use of GLP-1 RAs to Individualize Therapy in T2DM: Candid Conversations on Glycemic and Nonglycemic Effects
James R. Gavin III, MD, PhD
July 27, 2021
Medical Learning Institute, Inc.
Determining Which Patients Will Benefit From GLP-1 RAs: Applying Guidelines and Evidence to Individualize Treatment Decisions in T2DM
Vanita R. Aroda, MD
July 16, 2021
Medical Learning Institute, Inc.
Demystifying the Role of Incretin-Based Weight-Loss Pharmacotherapy: A Patient-Centered Approach to Overcoming Barriers and Addressing Underlying Causes of Obesity
Donna H. Ryan, MD, FTOS
July 15, 2021
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
Medical Learning Institute, Inc.
Going With Your Gut: Targeting Long-Term Weight Loss With Current and Emerging Incretin-Based Pharmacotherapy
Christopher D. Still, DO, FACP, FTOS / Alan C. Wittgrove, MD, FASMBS, FACS
July 07, 2021
Penn State College of Medicine
Management of Hyperlipidemia in the Family Medicine Setting: Diagnosis, Management, and the Role of Emerging Lipid-Lowering Therapies
James A. Underberg, MD, MS, FACPM, FACP, FNYAM, FASPC, FNLA
June 22, 2021
Medical Learning Institute, Inc.
Recognizing and Treating Hyperkalemia in Patients With Heart Failure and/or Chronic Kidney Disease: An Update for Hospitalists
George L. Bakris, MD
May 31, 2021
University of Florida College of Medicine
Lower Is Better: Novel Therapeutic Strategies Targeting PCSK9 for Reducing LDL-C Levels in Patients With Hyperlipidemia and ASCVD
Professor Kausik Ray
May 27, 2021
Medical Learning Institute, Inc.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
Richard K. Bogan, MD, FCCP, FAASM
May 18, 2021
Medical Learning Institute, Inc.
Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
Karl E. Anderson, MD
April 15, 2021
Medical Learning Institute, Inc.
Simulation – Partnering With Peers and Patients: Achieving T2DM Treatment Goals With GLP-1 RA Therapy
Jay H. Shubrook, DO, FAAFP, FACOFP
March 31, 2021

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView